Tracking Response in Advance of Investigational Trials, Borderline Study
NCT05025670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2023-03-27
Summary
TRAIT-BOR is an open-label psychotherapy treatment study for adults who meet the diagnostic criteria for Borderline Personality Disorder (BPD) and are seeking enrollment in a clinical trial of a novel compound to treat BPD. The current study seeks to determine if there are therapeutic benefits to more infrequent, short term, or longer term supportive psychotherapy.
Conditions
- Borderline Personality Disorder
Interventions
- BEHAVIORAL
-
Supportive psychotherapy
Participants will receive monthly 30-45 minute supportive psychotherapy sessions. Supportive psychotherapy is an integrative and eclectic psychotherapeutic approach, based upon the individual's needs and symptoms. It draws from elements of a variety of psychotherapeutic disciplines, including cognitive-behavior, psychodynamic, and interpersonal therapies.
Sponsors & Collaborators
-
Adams Clinical
lead NETWORK
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-05
- Primary Completion
- 2022-12-15
- Completion
- 2022-12-15
Countries
- United States
Study Locations
More Related Trials
-
Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
NCT02960763 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Sense of Identity in Patients Diagnosed With Borderline Personality Disorder. A Pilot Study
NCT04948905 ·Status: COMPLETED
-
Nalmefene in Alcohol Dependence and Borderline Personality Disorder
NCT02752503 ·Status: UNKNOWN ·Phase: NA
-
Treatment-Resistant Depression Registry
NCT00320372 ·Status: COMPLETED
-
Empathy Anomalies in Emotionally Unstable (Borderline) Personality Disorder
NCT05381649 ·Status: COMPLETED
-
Digital Interventions for Adults with Treatment-Resistant Depression: a Pilot Study
NCT06732089 ·Status: RECRUITING
-
Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients
NCT02088580 ·Status: COMPLETED ·Phase: NA
-
Methylation Status of BDNF Gene After Dialectical Behavior Therapy in BPD
NCT02134223 ·Status: COMPLETED ·Phase: NA
-
SHame prOpensity in bOrderline Personality Disorder
NCT03994510 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study of Botox for Depression
NCT01556971 ·Status: UNKNOWN ·Phase: PHASE4
-
Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder
NCT02972632 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
NCT00285766 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Clinical Study Experiences of People With Depression
NCT05937932 ·Status: NOT_YET_RECRUITING
-
Characterizing Dopamine Receptor Binding in Treatment Resistant Depression
NCT03537794 ·Status: RECRUITING
-
Stress Sensitivity and Reward Responsivity in Depression
NCT02798094 ·Status: COMPLETED
-
Characterization and Treatment of Adolescent Depression
NCT03388606 ·Status: RECRUITING
-
OptimizeD Pilot Study
NCT06153004 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Sleep in a Psychiatric Hospital
NCT07010718 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
NCT05531591 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Improvements in Mood and Sleep Trial
NCT06639477 ·Status: RECRUITING ·Phase: NA
-
Organized Self-Management Support Services for Chronic Depression
NCT01139060 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features
NCT04209166 ·Status: UNKNOWN ·Phase: NA
-
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
NCT06332261 ·Status: COMPLETED
-
Schema Therapy for Patients With Chronic Treatment Resistant Depression
NCT05833087 ·Status: RECRUITING ·Phase: NA
-
Prospective Clinical Cohort Study of Depression
NCT05775809 ·Status: ENROLLING_BY_INVITATION